Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2026-04-15

FDA Approved: RAMELTEON — Supplemental Application (Micro Labs Limited)

View source ↗

Summary

The FDA approved a supplemental application for ramelteon from Micro Labs Limited, under the ANDA supplemental process.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ramelteon (ramelteon)

Snippet

SUPPL AP for RAMELTEON (RAMELTEON)